Compania de Minas Buenaventura SAA ADR (BVN)vsVersamet Royalties Corporation Common Stock (VMET)
BVN
Compania de Minas Buenaventura SAA ADR
$29.72
-11.70%
BASIC MATERIALS · Cap: $8.27B
VMET
Versamet Royalties Corporation Common Stock
$11.82
-5.39%
BASIC MATERIALS · Cap: $1.26B
Smart Verdict
WallStSmart Research — data-driven comparison
Compania de Minas Buenaventura SAA ADR generates 3606% more annual revenue ($2.05B vs $55.27M). VMET leads profitability with a 58.4% profit margin vs 47.7%. BVN trades at a lower P/E of 7.9x. BVN earns a higher WallStSmart Score of 84/100 (A-).
BVN
Exceptional Buy84
out of 100
Grade: A-
VMET
Buy58
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+16.1%
Fair Value
$48.26
Current Price
$29.72
$18.54 discount
Intrinsic value data unavailable for VMET.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Keeps 48 of every $100 in revenue as profit
Strong operational efficiency at 52.5%
Revenue surging 103.0% year-over-year
Earnings expanding 139.4% YoY
Safe zone — low bankruptcy risk
Keeps 58 of every $100 in revenue as profit
Strong operational efficiency at 90.6%
Revenue surging 594.0% year-over-year
Earnings expanding 573.0% YoY
Conservative balance sheet, low leverage
Areas to Watch
No major concerns identified
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : BVN
The strongest argument for BVN centers on P/E Ratio, Profit Margin, Operating Margin. Profitability is solid with margins at 47.7% and operating margin at 52.5%. Revenue growth of 103.0% demonstrates continued momentum.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.4% and operating margin at 90.6%. Revenue growth of 594.0% demonstrates continued momentum.
Bear Case : BVN
No major red flags identified for BVN, but monitor valuation.
Bear Case : VMET
The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.
Key Dynamics to Monitor
VMET is growing revenue faster at 594.0% — sustainability is the question.
BVN generates stronger free cash flow (232M), providing more financial flexibility.
Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BVN scores higher overall (84/100 vs 58/100), backed by strong 47.7% margins and 103.0% revenue growth. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Compania de Minas Buenaventura SAA ADR
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Compaa de Minas Buenaventura SAA, a precious metals company, is dedicated to the exploration, extraction, concentration, smelting and commercialization of minerals and polymetallic metals in Peru, the United States, Europe and Asia. The company is headquartered in Lima, Peru.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing cutting-edge therapeutics for serious diseases, leveraging its proprietary metalloenzyme-based technology platform. The company is committed to addressing significant unmet medical needs in fungal infections and oncology, positioning itself as a leader in therapeutic innovation. With a diverse pipeline bolstered by strategic collaborations and a strong intellectual property portfolio, Viamet is well-prepared to advance its clinical initiatives and enhance shareholder value, aiming to redefine treatment approaches in its specialized therapeutic areas.
Compare with Other OTHER PRECIOUS METALS & MINING Stocks
Want to dig deeper into these stocks?